Skip to main content
Log in

Gastrointestinal and Retroperitoneal Manifestations of Type 1 Neurofibromatosis

  • Review Article
  • Published:
Journal of Gastrointestinal Surgery Aims and scope

Abstract

Background

Type 1 neurofibromatosis (NF1) is a genetic disease characterized by neoplastic and not neoplastic disorders, involving tissues of neuroectodermal or mesenchymal origin. The mainly involved districts are skin, central nervous system, and eye, and there is a wide range of severity of clinical presentations.

Data sources

Abdominal manifestations of NF1 comprehend five categories of tumors: neurogenic with neurofibromas, malignant peripheral nerve sheath tumors and ganglioneuromas, neuroendocrine with pheochromocytomas and carcinoids, non-neurogenic gastrointestinal stromal tumors, i.e., GISTs, and embryonal tumors and miscellaneous.

Conclusions

Early diagnosis of these abdominal manifestations is very important given the risk of malignancy, organic complications such as in the case of pheochromocytomas or hemorrhagic-obstructive complications such as in the case of the tumors of the gastrointestinal tract (GISTs and neurofibromas). The importance of an annual clinical evaluation on the part of a multidisciplinary pool of clinicians in highly specialized centers allows early detection of complications and of neoplastic transformation.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5

Similar content being viewed by others

References

  1. Huson SM, Compston DAS, Clark P, Harper PS. A genetic study of von Recklinghausen neurofibromatosis in South East Wales. Prevalence, fitness, mutation rate and effect of parental transmission on severity. J Med Genet 1989;26:704–711. doi:10.1136/jmg.26.11.704.

    Article  CAS  PubMed  Google Scholar 

  2. Von Recklinghausen FD. Ueber die Multiple Fibrome der Haut und ihre Beichung zu den Multiplen Neuromen. Berlin, Germany: Hirschwald, 1882.

    Google Scholar 

  3. Fallace MR, Marchuk DA, Anderson LB, Letcher R, Odeh HM, Saulino AM, Fountain JW, Brereton A, Nicholson J, Mitchell AL. Type 1 neurofibromatosis gene: identification of a larger transcript disrupted in three NG1 patients. Science 1990;249:181–186. doi:10.1126/science.2134734.

    Article  Google Scholar 

  4. Xu GF, O’Connel P, Viskochil D, Cawthon R, Robertson M, Culver M, Dunn D, Stevens J, Gesteland R, White R. The neurofibromatosis type 1 gene encodes a protein related to GAP. Cell 1990;62:599–608. doi:10.1016/0092-8674(90)90024-9.

    Article  CAS  PubMed  Google Scholar 

  5. Visckochil D, Buchberg AN, Xu G, Cawthon RM, Stevens J, Wolff RK, Culver M, Carey JC, Copeland NG, Jenkins NA. Deletions and a translocation interrupt a clone gene at the neurofibromatosis type 1 locus. Cell 1990;62:1887–1892.

    Google Scholar 

  6. Friedma JM, Riccardi VM. Neurofibromatosis: Phenotype, Natural History, and Pathogenesis, 3rd ed. Baltimore, MD: Johns Hopkins University Press, 1999.

    Google Scholar 

  7. Ruggeri M, Huson SM. The clinical and diagnostic implications of mosaicism in the neurofibromatoses. J Neurol 2001;56:1433–1443.

    Google Scholar 

  8. National Institutes of Health Consensus Divelopment Conference Statement. Neurofibromatosis. Arch Neurol (Chicago) 1988;45:575–578.

    Google Scholar 

  9. Gutmann DH, Aylsworth A, Carely JC, Carey JC, Korf B, Pyeritz RE, Rubenstein A, Viskochil D. The diagnostic evaluation and multidisciplinary management of neurofibromatosis 1 and neurofibromatosis 2. JAMA 1997;278:51–57. doi:10.1001/jama.278.1.51.

    Article  CAS  PubMed  Google Scholar 

  10. Huson SM, Harper PS, Compston DAS. Von Recklinghausen neurofibromatosis 1: clinical and population study in South East Wales. Brain 1988;111:55–81. doi:10.1093/brain/111.6.1355.

    Article  Google Scholar 

  11. Lubs ML, Bauer MS, Formas ME, Djoic B. Lisch nodules in neurofibromatosis type 1. N Engl J Med 1991;324:1264–1266.

    CAS  PubMed  Google Scholar 

  12. Tonsgard JH, Kwak SM, Short MP, Dachmann AH. CT imaging in adults with neurofibromatosis 1: frequent asymptomatic plexiform lesions. Neurology 1998;50:1755–1760.

    CAS  PubMed  Google Scholar 

  13. Listernick R, Louis DN, Packer RJ, Gutmann DH. Optic pathway gliomas in children with neurofibromatosis type 1: consensus statement from theNf1 optic pathway glioma study. Ann Neurol 1997;41(2):143–149. doi:10.1002/ana.410410204.

    Article  CAS  PubMed  Google Scholar 

  14. Listernick R, Ferner RE, Piersal L, Sharif S, Gutmann DH, Charrow J. Late onset optic pathway tumours in children with neurofibromatosis type1. Neurology 2004;63:1944–1946.

    CAS  PubMed  Google Scholar 

  15. Crawford AH Jr, Bagamery N. Osseus manifestation of neurofibromatosis in childhood. J Pediatr Orthop 1986;6:72–88.

    PubMed  Google Scholar 

  16. Kuoriletho T, Poyhonen M, Bloigu R, Heikkinen J, Vaananen K, Peltonen J. Decreased bone mineral density and content in neurofibromatosis type1: lowest local values are located in the load carrying parts of the body. Osteoporos Int 2005;16:928–936. doi:10.1007/s00198-004-1801-4.

    Article  Google Scholar 

  17. North KN, Riccardi V, Samango Sprouse C, Ferner R, Moore B, Legius E, Ratner N, Denckla MB. Cognitive function and academic performance in neurofibromatosis 1: consensus statement from the Nf1 Cognitive Disorder Task Force. Neurology 1997;48:1121–1127.

    CAS  PubMed  Google Scholar 

  18. Costa RM, Federov NB, Kogan JH, Murphy GG, Stern J, Ohno M, Kucherlapati R, Jacks T, Silva AJ. Mechanisms for the learning deficits in a mouse model neurofibromatosis 1. Nature 2002;415:526–530. doi:10.1038/nature711.

    Article  CAS  PubMed  Google Scholar 

  19. Di Paolo DP, Zimmerman RA, Rorke LB, Zackai EH, Bilaniuk LT, Yachnis AT. Neurofibromatosis type 1: pathologic substrate of high signal intensity foci in the brain. Radiology 1995;195:721–724.

    Google Scholar 

  20. Bognano JR, Edwards MK, Lee TA, Dunn DW, Roos KL, Klatte EC. Cranial MR imaging in neurofibromatosis. Am J Radiol 1998;151:381–388.

    Google Scholar 

  21. Friedman JM, Arbiser J, Epstein JA, Gutmann DH, Huot SJ, Lin AE, McManus B, Korf BR. Cardiovascular disease in neurofibromatosis 1: a report of the NF1 Cardiovascular Task Force. Genet Med 2003;4:105–111. doi:10.1097/00125817-200205000-00002.

    Article  Google Scholar 

  22. Messiaen LM, Callens T, Mortier G, Beysen D, Vandenbroucke I, Van Roy N, Speleman F, Paepee AD. Exhaustive mutation analysis of the Nf1 gene allows identification of 95% of mutations and reveals a high frequency of unusual splicing defects. Hum Mutat 2000;14:541–555. doi:10.1002/1098-1004(200006)15:6<541::AID-HUMU6>3.0.CO;2-N.

    Article  Google Scholar 

  23. Tonsgard JH, Yelavarthi KK, Cushner S, Short MP, Lindgren V. Do Nf1 gene deletions result in a characteristic phenotype? Am J Med Genet 1997;73:80–86. doi:10.1002/(SICI)1096-8628(19971128)73:1<80::AID-AJMG16>3.0.CO;2-N.

    Article  CAS  PubMed  Google Scholar 

  24. De Raedt T, Brems H, Wolkenstein P, Vidaud D, Pilotti S, Perrone F, Mautner V, Frahm S, Sciot R, Legius E. Elevated risk for MPNST in Nf1 microdeletions patients. Am J Hum Genet 2003;72:1288–1292. doi:10.1086/374821.

    Article  PubMed  Google Scholar 

  25. Verlinsky Y, Rechitsky S, Verlinsky O, Chistokhina A, Sharapova T, Masciangelo C, Levy M, Kaplan B, Lederer K, Kuliev A. Preimplantation diagnosis for neurofibromatosis. Reprod Biomed Online 2002;4:218–222.

    PubMed  Google Scholar 

  26. Levy AD, Patel N, Dow N, Abbott RM, Miettinem M, Sobin LH. From the archives of the AFIP: abdominal neoplasm in patients with neurofibromatosis type 1: radiologic-pathologic correlation. Radiographics 2005;25:455–480. doi:10.1148/rg.252045176.

    Article  PubMed  Google Scholar 

  27. Riccardi VM. Neurofibromatosis: Phenotype, Natural History and Pathogenesis, 2nd ed. Baltimore, MD: Johns Hopkins University Press, 1992.

    Google Scholar 

  28. Petersen JM, Ferguson DR. Gastrointestinal neurofibromatosis. J Clin Gastroenterol 1984;6:529–534. doi:10.1097/00004836-198412000-00008.

    Article  CAS  PubMed  Google Scholar 

  29. Miller WB, Boal DK, Teele R. Neurofibromatosis of the bladder: sonographic findings. J Clin Ultrasound 1983;11:460–462. doi:10.1002/jcu.1870110813.

    Article  PubMed  Google Scholar 

  30. Scheithauer BW, Woodruff JM, Erlandson RA. Tumours of the Peripheral Nervous System. Washington, DC: Armed Forces Institute of Pathology, 1999.

    Google Scholar 

  31. Fukuy T, Lu CC, Mitros FA. CT findings of plexiform neurofibromatosis involving the ileum and its mesentery. Clin Imaging 1994;18:142–145. doi:10.1016/0899-7071(94)90051-5.

    Article  Google Scholar 

  32. Bass JC, Korobkin M, Francio IR, Ellis JH, Cohan RH. Retroperitoneal plexiform neurofibromas: CT findings. AJR Am J Roentgenol 1994;163:617–620.

    CAS  PubMed  Google Scholar 

  33. Ros PR, Eshaghi N. Plexiform neurofibroma of the pelvis: CT and MRI findings. Magn Reson Imaging 1991;9:463–465. doi:10.1016/0730-725X(91)90436-P.

    Article  CAS  PubMed  Google Scholar 

  34. Bhagarva R, Parham DM, Lasater OE, Chari RS, Chen G, Fletcher BD. MR imaging differentiation of benign and malignant peripheral nerve sheath tumours: use of the target sign. Pediatr Radiol 1997;27:124–129. doi:10.1007/s002470050082.

    Article  Google Scholar 

  35. Mc Laughlin ME, Jacks T. Progesterone receptor expression in neurofibromas. Cancer 2003;63:752–755.

    CAS  Google Scholar 

  36. Packer RJ, Guttmann DH, Rubenstein A, Viskochil D, Zimmermann RA, Vezina G, Small J, Korf B. Plexiform neurofibromas in N1: toward biologic-based therapy. Neurology 2002;58:1461–1470.

    CAS  PubMed  Google Scholar 

  37. Ferner RE, Gutmann DH. International consensus statement on malignant peripheral nerve sheath tumours in neurofibromatosis 1. Cancer Res 2002;62:1573–1577.

    CAS  PubMed  Google Scholar 

  38. Evans DG, Baser ME, McGaughran J, Sharif S, Howard E, Maoran A. Malignant peripheral nerve sheath tumours in neurofibromatosis1. J Med Genet 2002;39:311–314. doi:10.1136/jmg.39.5.311.

    Article  CAS  PubMed  Google Scholar 

  39. D’Agostino AN, Soule EH, Miller RH. Primary malignant neoplasms of nerves (malignant neurilemomas) in patients without manifestations if multiple neurofibromatosis (von Recklinghausen disease). Cancer 1963;16:1003–1014. doi:10.1002/1097-0142(196308)16:8<1003::AID-CNCR2820160807>3.0.CO;2-S.

    Article  PubMed  Google Scholar 

  40. Hartley N, Rajesh A, Verma R, Sinha R, Sandrassegaran K. Abdominal manifestations of neurofibromatosis. J Comput Assist Tomogr 2008;32:4–8. doi:10.1097/rct.0b013e318054e1ca.

    Article  PubMed  Google Scholar 

  41. Hammond JA, Driedger AA. Detection of malignant change in neurofibromatosis (von Recklinghausen disease) by gallium-67 scanning. Can Med Assoc J 1978;119:352–353.

    CAS  PubMed  Google Scholar 

  42. Ducatman BS, Sheithauer BW, Piepgras DG, Reiman HM, Ilstrup DM. Malignant peripheral nerve sheath tumours: a clinical pathological study of 120 cases. Cancer 1986;57:2006–2021. doi:10.1002/1097-0142(19860515)57:10<2006::AID-CNCR2820571022>3.0.CO;2-6.

    Article  CAS  PubMed  Google Scholar 

  43. Shekitka KM, Sobin LH. Ganglioneuromas of the gastrointestinal tract: relation to von Recklinghausen disease and other multiple tumour syndromes. Am J Surg Pathol 1994;18:250–257. doi:10.1097/00000478-199403000-00004.

    Article  CAS  PubMed  Google Scholar 

  44. Hendi JM, Horton KM, Fishman EK. Somatostatinoma of the ampulla and appendical carcinoid in a patient with von Recklinghausen disease. J Comput Assist Tomogr 2005;29:418–428. doi:10.1097/01.rct.0000160448.49536.0f.

    Article  PubMed  Google Scholar 

  45. Burke AP, Federspiel BH, Sabin LH, Shekita KM, Helwig EB. Carcinoids of the duodenum: a histologic and immunohistochemical study of 65 tumors. Am J Surg Pathol 1989;13:828–837.

    CAS  PubMed  Google Scholar 

  46. Dayal Y, Tallberg KA, Nunmamacher G, De Lellis RA, Wolfew HJ. Duodenal carcinoids in patients with and without neurofibromatosis: a comparative study. Am J Surg Pathol 1986;10:348–357. doi:10.1097/00000478-198605000-00007.

    Article  CAS  PubMed  Google Scholar 

  47. Irvin GL, Fishman LW, Sher JA. Familial pheochromocytoma. Surgery 1983;94:938–940.

    PubMed  Google Scholar 

  48. Walther MM, Herring J, Enquist E, Kaiser HR, Linhean WM. Von Recklinghausen disease and pheochromocytomas. J Urol 1999;162:1582–1586. doi:10.1016/S0022-5347(05)68171-2.

    Article  CAS  PubMed  Google Scholar 

  49. Chetty R, Duhig JD. Bilateral pheochromocytoma–ganglioneuroma of the adrenal in type 1 neurofibromatosis. Am J Surg Pathol 1993;17:837–841. doi:10.1097/00000478-199308000-00009.

    Article  CAS  PubMed  Google Scholar 

  50. Teramoto S, Ota T, Maniwa A, Matsui T, Itaya N, Aoyagi K, Kusangi H, Narita M. Two von Recklinghausen disease cases with pheochromocytomas and gastrointestinal stromal tumours (GIST) in combination. Int J Urol 2007;14:73–74. doi:10.1111/j.1442-2042.2006.01601.x.

    Article  PubMed  Google Scholar 

  51. Miettinen M, Kopczynski J, Makhulouf HR, Sarlomo-Rikala M, Gyorffy H, Burke A, Sobin LH, Lasota J. Gastrointestinal stromal tumours, intramural leiomyomas and leiomyosarcomas in the duodenum: a clinicopathologic, immunohistochemical, and molecular genetic study of 167 cases. Am J Surg Pathol 2003;27:625–641. doi:10.1097/00000478-200305000-00006.

    Article  PubMed  Google Scholar 

  52. Ghrist TD. Gastrointestinal involvement in neurofibromatosis. Arch Intern Med 1963;112:357–362.

    CAS  PubMed  Google Scholar 

  53. Boldorini R, Tosoni A, Leutner M, Ribaldone R, Surico N, Cornello E, Min KW. Multiple small intestinal stromal tumours in a patient with previously unrecognised neurofbromatosis type 1: immunohistochemical and ultrastructural evaluation. Pathology 2001;33:390–395. doi:10.1080/00313020120063054.

    Article  CAS  PubMed  Google Scholar 

  54. Kinoshita K, Hirota S, Isozaki K, Ohashi A, Nishida T, Kitamura Y, Shinomura Y, Matsuzawa Y. Absence of c-kit gene mutations in gastrointestinal stromal tumours from neurofibromatosis type 1 patients. J Pathol 2004;202:80–85. doi:10.1002/path.1487.

    Article  CAS  PubMed  Google Scholar 

  55. Heinrich MC, Corless CL, Duensing A, Mc Greevey L, Chen CJ, Joseph N, Singer S, Griffith DJ, Haley A, Town A, Demetri GD, Fletcher CD, Fletcher JA. PDGFRA activating mutations in gastrointestinal stromal tumors. Science 2003;299:278. doi:10.1126/science.1079666.

    Article  CAS  Google Scholar 

  56. Stewart DR, Coreless CL, Rubin BP, Heinrich MC, Messiaen LM, Kessler LJ, Zhang PJ, Brooks DG. Mitotic recombination as evidence of alternative pathogenesis of gastrointestinal stromal tumours in neurofibromatosis type 1. J Med Genet 2007;44:61. doi:10.1136/jmg.2006.043075.

    Article  Google Scholar 

  57. Kramer K, Hasel C, Aschoff JA, Brunes HD, Wuerl P. Multiple gastrointestinal stromal tumours and bilateral pheochromocytoma in neurofibromatosis. World J Gastroenterol 2007;13:3384–3387.

    PubMed  Google Scholar 

  58. Levy AD, Patel N, Abbott RM, Dow N, Miettinem M, Sobin LH. Gastrointestinal stromal tumours in patients with neurofibromatosis: imaging features with clinicopathologic correlation. AJR Am J Roentgenol 2004;183:1629–1635.

    PubMed  Google Scholar 

  59. Mietttinem M, Fetsch JF, Sobin LH, Lasota J. Gastrointestinal stromal tumours in patients with neurofibromatosis 1. A clinicopathological and molecular genetic study of 45 cases. Am J Surg Pathol 2006;30:90–96. doi:10.1097/01.pas.0000176433.81079.bd.

    Article  Google Scholar 

  60. Kalender ME, Seviniv A, Tutar E, Sirikci A, Camici C. Effect of sunitinib on metastatic gastrointestinal stromal tumour in patients with neurofibromatosis type 1: a case report. World J Gastroenterol 2007;13:2629–2632.

    PubMed  Google Scholar 

  61. Hayflick SJ, Hofmann KJ, Tunnesen WW, Levienthal BG, Dudgeon DL. Neurofibromatosis 1: recognition and management of associated neuroblastoma. Pediatr Dermatol 1990;7:293–295. doi:10.1111/j.1525-1470.1990.tb01028.x.

    Article  CAS  PubMed  Google Scholar 

  62. Costi R, Caruana P, Sarli L, Violi V, Roncoroni R, Bordi C. Ampullary adenocarcinoma in neurofibromatosis type 1: case reported in literature review. Mod Pathol 2001;14:1169–1174. doi:10.1038/modpathol.3880454.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Giuseppe Cavallaro.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Basile, U., Cavallaro, G., Polistena, A. et al. Gastrointestinal and Retroperitoneal Manifestations of Type 1 Neurofibromatosis. J Gastrointest Surg 14, 186–194 (2010). https://doi.org/10.1007/s11605-009-0940-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11605-009-0940-5

Keywords

Navigation